Michelle Horner
Amgen (United States)(US)
Publications by Year
Research Areas
T-cell and B-cell Immunology, Sphingolipid Metabolism and Signaling, Monoclonal and Polyclonal Antibodies Research, Carbohydrate Chemistry and Synthesis, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia(1991)399 cited
- → Alternative Strategies for Toxicity Testing of Species-Specific Biopharmaceuticals(2009)97 cited
- → Evaluation of the Renal Effects of an Antisense Phosphorothioate Oligodeoxynucleotide in Monkeys(1999)74 cited
- → Discovery of TRPM8 Antagonist (S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine(2018)61 cited
- → Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5(2010)54 cited
- → Pharmacokinetics and Tissue Disposition in Monkeys of an Antisense Oligonucleotide Inhibitor of Ha-Ras Encapsulated in Stealth Liposomes(1999)46 cited
- → Pharmacokinetics and Urinary Excretion of Amikacin in Low-Clearance Unilamellar Liposomes after a Single or Repeated Intravenous Administration in the Rhesus Monkey(1999)40 cited
- → Homeostasis of Human NK Cells Is Not IL-15 Dependent(2013)38 cited
- → Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS(2010)37 cited
- → Preclinical development ofAMG139, a human antibody specifically targetingIL‐23(2014)31 cited